The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions-Reference-Cited by-同舟云学术

The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions

Published:2013-08-14 Issue:8 Volume:8 Page:e71266
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bhullar Jasjeet,Natarajan Karthika,Shukla Suneet,Mathias Trevor J.,Sadowska Mariola,Ambudkar Suresh V.,Baer Maria R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference70 articles.

1. Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias;CE Carow;Blood,1996

2. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells;O Rosnet;Leukemia,1996

3. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials;PD Kottaridis;Blood,2001

4. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm;S Fröhling;Blood,2002

5. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease;S Schnittger;Blood,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport;Pharmaceuticals;2023-11-12

2. Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2;Drug Resistance Updates;2023-11

3. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance;Recent Patents on Anti-Cancer Drug Discovery;2023-08-31

4. Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape;Expert Review of Clinical Pharmacology;2023-02-01

5. Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells;International Journal of Molecular Sciences;2022-10-23